Tacrolimus as First-Line Therapy for IIM-ILD in a U.S. Cohort
The following is a summary of “Tacrolimus as first line therapy in a U.S. cohort of idiopathic inflammatory myopathies related interstitial lung disease,” published in the February 2025 issue of Rheumatology by Harris et al. Calcineurin inhibitors treat idiopathic...